WuXi Biologics Congratulates Tychan on the World’s First Yellow Fever Antibody

WuXi Biologics, a leading global open-access biologics technology platform company offering end-to-end solutions fo...

November 19, 2019 | Tuesday | News
WuXi AppTec’s LTD expands toxicology facility in China

WuXi AppTec, a leading global provider of R&D and manufacturing services enabling companies in the pharmaceutical, b...

November 18, 2019 | Monday | News
ITM, CIRC promote medical radioisotopes in China

Germany based ITM Isotopen Technologien München AG (ITM), a biotechnology and radiopharmaceutical group of companie...

November 20, 2019 | Wednesday | News
NUS to set up research translation unit in China

National University of Singapore (NUS) is collaborating with the People’s Government of Guangzhou Municipality and...

November 22, 2019 | Friday | News
PSGL-1 immunotherapy to activate anti-tumor inflammatory response

3SBio Inc. and Verseau Therapeutics, Inc. on 18 Nov 2019 announced the selection of VTX-0811, a monoclona...

November 18, 2019 | Monday | News
BeiGene receives its first FDA approval

BeiGene, Ltd., China, a commercial-stage biopharmaceutical company focused on developing and commercializing innovative ...

November 18, 2019 | Monday | News
I-Mab to kick off clinical trials for monoclonal antibody TJM2 in China

I-Mab Biopharma ("I-Mab"), a China and U.S.-based clinical-stage biopharmaceutical company exclusively focused...

November 15, 2019 | Friday | News
111 to establish healthcare retail channel with HEC

111, Inc., a leading integrated online and offline healthcare platform, announced  that it will establish an integr...

November 15, 2019 | Friday | News
Thermo Fisher opens customer solution center in China

Thermo Fisher Scientific Inc., the world leader in serving science, has announced the official opening of a Customer Sol...

November 14, 2019 | Thursday | News
Novaliq, Jiangsu Hengrui focus on treatment of dry eye disease

Novaliq GmbH, a Germany based pharmaceutical company focusing on first- and best-in-class ocular therapeutics, and Jiang...

November 14, 2019 | Thursday | News
LEO Pharma, HitGen to develop novel class of derma drugs

Denmark headquartered LEO Pharma A/S and China based HitGen Inc. are pleased to announce that HitGen and LEO Pharma expa...

November 13, 2019 | Wednesday | News
GE Healthcare, Akeso Pharma to expedite novel therapy manufacturing in China

Akeso Pharmaceuticals, a biotech company specializing in the development and commercialization of novel biologics, will ...

November 12, 2019 | Tuesday | News
China approves Alzheimer's drug

The State Food and Drug Administration of China (CFDA) has conditionally approved the application for the listing o...

November 11, 2019 | Monday | News
Roxadustat Phase III study shows positive efficacy in patients with anaemia from CKD

AstraZeneca and FibroGen Inc. (FibroGen) have presented pooled efficacy and cardiovascular (CV) safety analyses from the...

November 11, 2019 | Monday | News
E China's Hangzhou strengthens to establish world-class biomedical innovation city

Hangzhou, capital of east China's Zhejiang Province, is endeavouring to build itself into a world-class biomed...

November 10, 2019 | Sunday | News
MMHP to build the world's largest human microbiome database

The "Million Microbiome of Humans Project" (MMHP) was officially launched at the 14th International Conference on Genomi...

November 8, 2019 | Friday | News
Lucence, MEDx to co-develop cutting-edge cancer care tests

China based MEDx (Suzhou) Translational Medicine, and Singapore-based Lucence - a leading genomic medicine company - hav...

November 11, 2019 | Monday | News
AstraZeneca announces three large-scale initiatives in China

AstraZeneca has announced three large-scale initiatives to build on the Company’s long-standing commitment to Chin...

November 8, 2019 | Friday | News